Bærum, Norway – June 5, 2025 – Oxipit, a leading provider of AI-driven medical imaging solutions, announced the collaboration with Vestre Viken Health Trust in launching Norway's first pilot project for AI-powered thoracic (lung) X-ray imaging. This initiative will evaluate ChestLink, the world’s first autonomous AI tool for reporting normal chest X-rays.

FIDI (Fundação Instituto de Pesquisa e Estudo de Diagnóstico por Imagem) is one of Latin America's largest radiology service providers, delivering more than 400,000 diagnostic studies each month across 90 sites in Brazil. In 2024, FIDI introduced Oxipit’s AI-powered chest X-ray support tool in emergency departments, where fast, consistent interpretation is critical and real-time radiologist input is not always available.

February 27, 2025 — Vilnius, Lithuania — Oxipit, a leading AI-driven healthcare technology company, has announced the appointment of Dr. Robert Epstein to its Radiology Advisory Board. His expertise in radiology and healthcare strategy will support Oxipit’s mission to enhance diagnostic workflows worldwide through trusted AI solutions, enabling faster, more precise diagnoses and advancing patient care.

February 17, 2025 — Geneva, Switzerland — Unilabs, a leading diagnostic services provider in Europe, announced the selection of AI solutions from Oxipit, a pioneering medical imaging AI company, to deploy solutions for chest X-rays throughout Unilabs’ European network. This partnership will see Oxipit’s AI solutions, ChestLink and ChestEye, integrated into Unilabs’ radiology workflows, streamlining chest X-ray reporting through automated triage and second-reading capabilities. The agreement covers the option to use these solutions within the entire Unilabs group in Europe, with the initial rollout starting in Portugal.

Oxipit further expands commercial availability of its solutions via partnership with deepc. This collaboration will integrate Oxipit’s advanced AI solutions - ChestLink, ChestEye, and ChestEye Quality - into the deepcOS platform, delivering effortless access to Oxipit solutions directly within existing Healthcare IT systems, with just one simple integration.

Oxipit, a leading AI radiology solutions provider, has appointed senior health tech executive, Peter Corscadden, as Chief Executive Officer to strengthen its global footprint.

Blackford, the pioneering strategic radiology AI platform and solutions provider, today announced a partnership with AI medical imaging company Oxipit. The agreement will bring innovative Oxipit’s chest x-ray products to Blackford’s enterprise AI platform.

Leiden University Medical Center (The Netherlands) expands cooperation with AI medical imaging company Oxipit by deploying the latest Oxipit product - AI quality assurance tool for CT Pulmonary Embolism (PE). The LUMC deployment was facilitated through the radiology imaging solution by Sectra and its integration capabilities.

At the European Congress of Radiology in Vienna Oxipit announced that its diagnostic AI solutions will be available on the CARPL platform. CARPL platform users will have access to the full Oxipit AI product portfolio: ChestLink for healthy patient report automation, Quality - for real-time quality assurance and ChestEye - for preliminary reports. The move further builds on Oxipit strategy to increase global reach of company’s products.

The regulatory approval paves the way for ChestEye deployments in the Brazilian market. The application is already cleared for use in Europe and Australia. The Brazilian Health Regulatory Agency’s approval is one of Oxipit steps to increase global reach for company products.